U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    SEMA3A semaphorin 3A [ Homo sapiens (human) ]

    Gene ID: 10371, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    PIEZO1 Promotes Odontoblast-Mediated Reactionary Dentinogenesis via SEMA3A.

    PIEZO1 Promotes Odontoblast-Mediated Reactionary Dentinogenesis via SEMA3A.
    Huang P, Jiang RX, Wang F, Qiao WW, Ji YT, Meng LY, Bian Z.

    08/29/2024
    Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.

    Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.
    Lupo F, Pezzini F, Pasini D, Fiorini E, Adamo A, Veghini L, Bevere M, Frusteri C, Delfino P, D'agosto S, Andreani S, Piro G, Malinova A, Wang T, De Sanctis F, Lawlor RT, Hwang CI, Carbone C, Amelio I, Bailey P, Bronte V, Tuveson D, Scarpa A, Ugel S, Corbo V., Free PMC Article

    08/7/2024
    Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization.

    Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization.
    Yang R, Yang F, Wei Y, Huang B, Cao T, Tan H, Liu D, Zou Q, Wen J, Wen L, Lu X, Yu C, Cai H, Xie X, Jiang S, Yao S, Liang Y.

    07/30/2024
    Role of Semaphorin 3A in common psychiatric illnesses such as schizophrenia, depression, and anxiety.

    Role of Semaphorin 3A in common psychiatric illnesses such as schizophrenia, depression, and anxiety.
    Yang Y, Guan W, Sheng XM, Gu HJ.

    07/29/2024
    Sema3A Alleviates the Malignant Behaviors of Gastric Cancer Cells by Inhibiting NRP-1.

    Sema3A Alleviates the Malignant Behaviors of Gastric Cancer Cells by Inhibiting NRP-1.
    Yang H, Zhou Y, Wang L, Lv M, Sun J, Luo Z, He J.

    07/18/2024
    Semaphorin 3 a restores the ability of type 1 regulatory T cells to suppress food allergy.

    Semaphorin 3 a restores the ability of type 1 regulatory T cells to suppress food allergy.
    Gao P, Song S, Wang Y, Liu H, Wang X, Shu Q, Yang P, Zheng P.

    04/26/2024
    Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8[+] T cells.

    Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8(+) T cells.
    Barnkob MB, Michaels YS, André V, Macklin PS, Gileadi U, Valvo S, Rei M, Kulicke C, Chen JL, Jain V, Woodcock VK, Colin-York H, Hadjinicolaou AV, Kong Y, Mayya V, Mazet JM, Mead GJ, Bull JA, Rijal P, Pugh CW, Townsend AR, Gérard A, Olsen LR, Fritzsche M, Fulga TA, Dustin ML, Jones EY, Cerundolo V., Free PMC Article

    04/17/2024
    Expression of semaphorin 3A (SEMA3A) in breast cancer subtypes.

    Expression of semaphorin 3A (SEMA3A) in breast cancer subtypes.
    Andryszak N, Kurzawa P, Krzyżaniak M, Ruchała M, Nowicki M, Iżycki D, Czepczyński R., Free PMC Article

    02/29/2024
    Sema3A secreted by sensory nerve induces bone formation under mechanical loads.

    Sema3A secreted by sensory nerve induces bone formation under mechanical loads.
    Mei H, Li Z, Lv Q, Li X, Wu Y, Feng Q, Jiang Z, Zhou Y, Zheng Y, Gao Z, Zhou J, Jiang C, Huang S, Li J., Free PMC Article

    02/1/2024
    Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancer.

    Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancer.
    Ma RY, Yang LN, Chen JN, Chen RJ, Zhang LW, Wang XQ.

    03/22/2023
    CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.

    CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
    Eiza N, Sabag AD, Kessler O, Neufeld G, Vadasz Z.

    02/14/2023
    Semaphorin 3A-Neuropilin-1 Signaling Modulates MMP13 Expression in Human Osteoarthritic Chondrocytes.

    Semaphorin 3A-Neuropilin-1 Signaling Modulates MMP13 Expression in Human Osteoarthritic Chondrocytes.
    Stöckl S, Reichart J, Zborilova M, Johnstone B, Grässel S., Free PMC Article

    12/10/2022
    Semaphorin 3A protects against alveolar bone loss during orthodontic tooth movement in mice with periodontitis.

    Semaphorin 3A protects against alveolar bone loss during orthodontic tooth movement in mice with periodontitis.
    Satomi K, Nishimura K, Igarashi K.

    09/24/2022
    The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis.

    The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis.
    Eiza N, Garty M, Staun-Ram E, Miller A, Vadasz Z.

    05/28/2022
    Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.

    Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.
    Kart Bayram GS, Erden A, Bayram D, Özdemir B, Karakaş Ö, Apaydın H, Ateş O, Güven SC, Armağan B, Gök K, Maraş Y, Omma A, Küçükşahin O, Topçuoğlu C, Erten Ş.

    05/14/2022
    Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.

    Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
    Doron R, Merav L, Nasrin E, Adi SD, Elias T, Gleb S, Itzhak R, Michael R, Zahava V.

    04/9/2022
    Multiple, independent, common variants at RET, SEMA3 and NRG1 gut enhancers specify Hirschsprung disease risk in European ancestry subjects.

    Multiple, independent, common variants at RET, SEMA3 and NRG1 gut enhancers specify Hirschsprung disease risk in European ancestry subjects.
    Kapoor A, Nandakumar P, Auer DR, Sosa MX, Ross H, Bollinger J, Yan J, Berrios C, Hirschsprung Disease Research Collaborative (HDRC), Chakravarti A., Free PMC Article

    12/18/2021
    MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.

    MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.
    Barlak N, Capik O, Kilic A, Sanli F, Aytatli A, Yazici A, Karatas EA, Ortucu S, Karatas OF.

    11/13/2021
    Immunosuppressive Regulation of Dendritic Cells and T Cells in Allergic Rhinitis by Semaphorin 3A.

    Immunosuppressive Regulation of Dendritic Cells and T Cells in Allergic Rhinitis by Semaphorin 3A.
    Liu H, Xia J, Chen Y, Ai J, Wang T, Tan G.

    11/6/2021
    Review of the function of SEMA3A in lymphatic vessel maturation and its potential as a candidate gene for lymphedema: Analysis of three families with rare causative variants.

    Review of the function of SEMA3A in lymphatic vessel maturation and its potential as a candidate gene for lymphedema: Analysis of three families with rare causative variants.
    Ricci M, Daolio C, Amato B, Kenanoglu S, Veselenyiova D, Kurti D, Dautaj A, Baglivo M, Basha SH, Priya S, Serrani R, Dundar M, Krajcovic J, Bertelli M.

    10/23/2021
    MicroRNA-145 suppresses osteogenic differentiation of human jaw bone marrow mesenchymal stem cells partially via targeting semaphorin 3A.

    MicroRNA-145 suppresses osteogenic differentiation of human jaw bone marrow mesenchymal stem cells partially via targeting semaphorin 3A.
    Jin Y, Hong F, Bao Q, Xu Q, Duan R, Zhu Z, Zhang W, Ma C.

    10/2/2021
    Semaphorin3A released from human dental pulp cells inhibits the increase in interleukin-6 and CXC chemokine ligand 10 production induced by tumor necrosis factor-alpha through suppression of nuclear factor-kappaB activation.

    Semaphorin3A released from human dental pulp cells inhibits the increase in interleukin-6 and CXC chemokine ligand 10 production induced by tumor necrosis factor-α through suppression of nuclear factor-κB activation.
    Shindo S, Kumagai T, Shirawachi S, Takeda K, Shiba H.

    08/14/2021
    Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.

    Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.
    Lucarini G, Simonetti O, Lazzarini R, Giantomassi F, Goteri G, Offidani A.

    07/31/2021
    Further delineation of a recognizable type of syndromic short stature caused by biallelic SEMA3A loss-of-function variants.

    Further delineation of a recognizable type of syndromic short stature caused by biallelic SEMA3A loss-of-function variants.
    Gileta AF, Helgeson ML, Leonard JMM, Pyle LC, Subramanian HP, Arndt K, Hawkes CP, Del Gaudio D., Free PMC Article

    07/24/2021
    [Expression of Semaphorin 3A after spinal cord injury].

    [Expression of Semaphorin 3A after spinal cord injury].
    Wang GY, Cheng ZJ, He XJ, Yang BH, Li HP.

    07/10/2021
    firstprevious page of 7 nextlast